🇺🇸
United States · US · US:54436-275_c8d74eb6-fa94-446a-8307-091436a536dc
XYOSTED
In shortageOrange BookUNIISPLATC G03BA03
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerAntares Pharma, Inc.
CountryUS (United States)
ATC codeG03BA03
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 3
- ndc1154436275011 SYRINGE in 1 CARTON (54436-275-01) / .5 mL in 1 SYRINGE (54436-275-03)
- ndc1154436275044 SYRINGE in 1 CARTON (54436-275-04) / .5 mL in 1 SYRINGE (54436-275-02)
- ndc1154436275051 SYRINGE in 1 CARTON (54436-275-05) / .5 mL in 1 SYRINGE (54436-275-02)
Annotations
UNII (FDA Substance ID)
7Z6522T8N9
TESTOSTERONE ENANTHATE
RxCUI 37859
Orange Book
N209863
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Testosterone Gel; Gel, Metered
Raw payload (JSON)
{
"unii": {
"unii": "7Z6522T8N9",
"rxcui": "37859",
"inchikey": "VOCBWIIFXDYGNZ-IXKNJLPQSA-N",
"display_name": "TESTOSTERONE ENANTHATE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "SUBCUTANEOUS",
"spl_meta": {
"8a3d204c-be26-49e0-8599-0ac12a272e81": {
"match": "brand_token",
"title": "XYOSTED (TESTOSTERONE ENANTHATE) INJECTION [ANTARES PHARMA, INC.]",
"spl_version": "16",
"published_date": "2026-04-27"
}
},
"productid": "54436-275_c8d74eb6-fa94-446a-8307-091436a536dc",
"productndc": "54436-275",
"dosage_form": "INJECTION",
"orange_book": {
"appl_no": "209863",
"products": [
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "50MG/0.5ML (50MG/0.5ML)",
"product_no": "001",
"approval_date": "Sep 28, 2018"
},
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "75MG/0.5ML (75MG/0.5ML)",
"product_no": "002",
"approval_date": "Sep 28, 2018"
},
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "100MG/0.5ML (100MG/0.5ML)",
"product_no": "003",
"approval_date": "Sep 28, 2018"
}
],
"appl_type": "N"
},
"dea_schedule": "CIII",
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "TESTOSTERONE ENANTHATE",
"shortage_reason": "Testosterone Gel; Gel, Metered",
"shortage_status": "current",
"proprietary_name": "XYOSTED",
"active_ingred_unit": "mg/.5mL",
"application_number": "NDA209863",
"marketing_category": "NDA",
"nonproprietary_name": "testosterone enanthate",
"start_marketing_date": "20181115",
"active_numerator_strength": "75"
}Related drugs
Other records sharing ATC code G03BA03.
- GBAndroderm 5mg/24hours transdermal patchesImported (United States)
- GBAndrofeme 1% creamImported (Australia)
- 🇺🇸AndroGelASCEND Therapeutics U.S., LLC
- 🇺🇸AndroGelASCEND Therapeutics U.S., LLC
- 🇺🇸AndroGelASCEND Therapeutics U.S., LLC
- 🇺🇸AndroGelASCEND Therapeutics U.S., LLC
- CZANDROGELBesins Healthcare S.A., Ixelles
- CZANDROGELBesins Healthcare S.A., Ixelles
Access this data programmatically
Query XYOSTED and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.